
FDA's pilot program aims to improve the accuracy and reliability of diagnostic biomarker tests for cancer treatment decisions.


coremsg

The FDA expressed concern that some laboratory-developed tests may not be as reliable or perform as well as FDA-authorized tests. The pilot program will provide more scrutiny of these tests.

FDA Pilot Program Aims to Reduce Risk of Diagnostic Tests for Cancer

fda-pilot-program-aims-to-reduce-risk-of-diagnostic-tests-for-cancer


FDA Pilot Program Aims to Reduce Risk of Diagnostic Tests for Cancer
